Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a ...

Shares of Bausch Health, Inc. BHC gained 14.7% in a week on reports of refinancing its debt to enable the impending sale of its eye care company, Bausch + Lomb BLCO. The industry declined 0.6% during ...

In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to ...

Tears evaporate and may cause dryness and irritation. Learn what evaporative dry eye is and what remedies to try for it.

Laughter therapy for dry eye disease worked in reducing discomfort. It improved tear stability, gland function, and mental ...

The global ophthalmic eye drop market is poised for steady growth over the next decade. The market, which was valued at USD ...

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned ...

Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option AgreementOption entitles Glaukos to exclusive global ...

Bausch + Lomb (NYSE:BLCO) is exploring a potential sale as part of an effort to resolve issues related to its separation from parent company Bausch Health, which is burdened with significant debt, as ...

A study reveals laughter exercise is as effective as artificial tears for dry eye disease, improving symptoms and tear film ...

Investors are pouring money into corporate bonds, risk premiums are grinding tighter, and the Federal Reserve’s interest rate ...